Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehdi Touat

Showing results (91-100 of 93) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 93 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 18, 2023
Inaugural Results of the Individualized Screening Trial of Innovative Glioblastoma Therapy: A Phase II Platform Trial for Newly Diagnosed Glioblastoma Using Bayesian Adaptive RandomizationRifaquat Rahman, Lorenzo Trippa, Eudocia Q Lee, et al.
Nature Communications|July 31, 2025
A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomasApril A Apfelbaum, Eric Morin, Dominik Sturm, et al.
Nature|April 24, 2020
Mechanisms and therapeutic implications of hypermutation in gliomasMehdi Touat, Yvonne Y Li, Adam N Boynton, et al.
Pageof 10

Showing results (91-100 of 93) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 93 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 18, 2023
Inaugural Results of the Individualized Screening Trial of Innovative Glioblastoma Therapy: A Phase II Platform Trial for Newly Diagnosed Glioblastoma Using Bayesian Adaptive RandomizationRifaquat Rahman, Lorenzo Trippa, Eudocia Q Lee, et al.
Nature Communications|July 31, 2025
A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomasApril A Apfelbaum, Eric Morin, Dominik Sturm, et al.
Nature|April 24, 2020
Mechanisms and therapeutic implications of hypermutation in gliomasMehdi Touat, Yvonne Y Li, Adam N Boynton, et al.
Pageof 10